Weiss Multi-Strategy Advisers’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-178,254
| Closed | -$10.3M | – | 72 |
|
|
2023
Q4 | $10.3M | Buy |
178,254
+5,575
| +3% | +$298K | 0.25% | 98 |
|
|
2023
Q3 | $9.12M | Sell |
172,679
-117,937
| -41% | -$6.19M | 0.22% | 131 |
|
|
2023
Q2 | $15.7M | Buy |
290,616
+89,420
| +44% | +$4.67M | 0.32% | 79 |
|
|
2023
Q1 | $10.1M | Sell |
201,196
-79,788
| -28% | -$3.76M | 0.24% | 124 |
|
|
2022
Q4 | $13M | Sell |
280,984
-27,128
| -9% | -$1.17M | 0.37% | 78 |
|
|
2022
Q3 | $11.9M | Buy |
308,112
+260,576
| +548% | +$10.5M | 0.32% | 101 |
|
|
2022
Q2 | $1.77M | Sell |
47,536
-84,354
| -64% | -$3.43M | 0.05% | 404 |
|
|
2022
Q1 | $5.84M | Buy |
131,890
+9,495
| +8% | +$411K | 0.14% | 244 |
|
|
2021
Q4 | $5.2M | Buy |
122,395
+1,034
| +0.9% | +$43.5K | 0.12% | 230 |
|
|
2021
Q3 | $5.27M | Buy |
121,361
+1,361
| +1% | +$60.2K | 0.11% | 239 |
|
|
2021
Q2 | $5.13M | Sell |
120,000
-1,046
| -0.9% | -$44K | 0.11% | 257 |
|
|
2021
Q1 | $4.68M | Buy |
121,046
+11,631
| +11% | +$440K | 0.1% | 263 |
|
|
2020
Q4 | $3.93M | Sell |
109,415
-585
| -0.5% | -$21.1K | 0.08% | 295 |
|
|
2020
Q3 | $4.2M | Sell |
110,000
-8,501
| -7% | -$328K | 0.11% | 254 |
|
|
2020
Q2 | $4.16M | Buy |
118,501
+18,501
| +19% | +$666K | 0.12% | 231 |
|
|
2020
Q1 | $3.26M | Buy |
100,000
+31,000
| +45% | +$1.21M | 0.13% | 209 |
|
|
2019
Q4 | $3.12M | Buy |
69,000
+4,000
| +6% | +$167K | 0.05% | 374 |
|
|
2019
Q3 | $2.65M | Hold |
65,000
| – | – | 0.05% | 346 |
|
|
2019
Q2 | $2.79M | Sell |
65,000
-2,000
| -3% | -$76.9K | 0.07% | 259 |
|
|
2019
Q1 | $2.57M | Hold |
67,000
| – | – | 0.06% | 305 |
|
|
2018
Q4 | $2.37M | Buy |
67,000
+16,761
| +33% | +$608K | 0.1% | 214 |
|
|
2018
Q3 | $1.93M | Buy |
50,239
+913
| +2% | +$31.9K | 0.05% | 331 |
|
|
2018
Q2 | $1.61M | Buy |
49,326
+4,326
| +10% | +$130K | 0.04% | 374 |
|
|
2018
Q1 | $1.23M | Sell |
45,000
-5,000
| -10% | -$136K | 0.04% | 395 |
|
|
2017
Q4 | $1.24M | Buy |
50,000
+10,000
| +25% | +$276K | 0.03% | 415 |
|
|
2017
Q3 | $1.17M | Sell |
40,000
-25,800
| -39% | -$713K | 0.04% | 363 |
|
|
2017
Q2 | $1.82M | Sell |
65,800
-4,625
| -7% | -$123K | 0.08% | 300 |
|
|
2017
Q1 | $1.75M | Sell |
70,425
-27
| -0% | -$657 | 0.07% | 311 |
|
|
2016
Q4 | $1.52M | Sell |
70,452
-9,922
| -12% | -$216K | 0.07% | 239 |
|
|
2016
Q3 | $1.91M | Sell |
80,374
-11,295
| -12% | -$269K | 0.12% | 222 |
|
|
2016
Q2 | $2.14M | Sell |
91,669
-36,119
| -28% | -$781K | 0.17% | 177 |
|
|
2016
Q1 | $2.4M | Sell |
127,788
-36
| -0% | -$632 | 0.1% | 243 |
|
|
2015
Q4 | $2.36M | Sell |
127,824
-1,361
| -1% | -$24.4K | 0.16% | 158 |
|
|
2015
Q3 | $2.12M | Buy |
129,185
+54,003
| +72% | +$923K | 0.09% | 182 |
|
|
2015
Q2 | $1.33M | Buy |
75,182
+182
| +0.2% | +$3.25K | 0.05% | 298 |
|
|
2015
Q1 | $1.33M | Sell |
75,000
-10,000
| -12% | -$158K | 0.06% | 294 |
|
|
2014
Q4 | $1.13M | Sell |
85,000
-45,000
| -35% | -$575K | 0.04% | 268 |
|
|
2014
Q3 | $1.53M | Sell |
130,000
-4,920
| -4% | -$62K | 0.04% | 331 |
|
|
2014
Q2 | $1.72M | Sell |
134,920
-2,340
| -2% | -$30.4K | 0.04% | 353 |
|
|
2014
Q1 | $1.86M | Sell |
137,260
-11,990
| -8% | -$157K | 0.04% | 363 |
|
|
2013
Q4 | $1.79M | Buy |
+149,250
| New | +$1.76M | 0.04% | 343 |
|
Other funds holding BSX
Weiss Multi-Strategy Advisers's BSX Position: Q1 2024 in Review
Weiss Multi-Strategy Advisers sold out of Boston Scientific (BSX) in Q1 2024, closing a stake of 178,254 shares — an estimated $10.3M sold.
Weiss Multi-Strategy Advisers first reported a position in BSX in Q4 2013 and held it in 41 quarters. The position peaked at $15.7M in Q2 2023. 1,222 funds tracked by Wall St. Rank hold BSX as of Q1 2024.
- Weiss Multi-Strategy Advisers reported no remaining Boston Scientific position as of Q1 2024 after selling out during the quarter.
- Weiss Multi-Strategy Advisers sold 178,254 Boston Scientific shares in Q1 2024, an estimated $10.3M.
- Weiss Multi-Strategy Advisers first reported a position in Boston Scientific in Q4 2013 and held it in 41 quarters.
- Weiss Multi-Strategy Advisers's Boston Scientific position peaked at $15.7M in Q2 2023.
- 1,222 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2024.
Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2024.